ERBB3 and lung cancer: Engelman and colleagues demonstrated that crosstalk between EGFR and Met was mediated by phosphorylation and signaling from HER3 to Akt in lung cancer cell lines and that this crosstalk mediated resistance to EGFR TKIs [7].